Zenas BiopharmaZBIO

13F holders, Q3 2024 (September 30)
44holders
4famous investors
$16.90avg. 13F price*

At the end of Q3 2024, 44 institutions reported holding Zenas Biopharma Inc. (ZBIO) in their 13F filings. The largest holders were SR One Capital Management, LP ($83.1M), NEA Management Company, LLC ($44.2M) and FMR LLC ($33.8M). 4 famous investors held it, including George Soros (0.0% of Soros Fund Management's portfolio), Steve Cohen (0.0% of Point72 Asset Management's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Zenas Biopharma Inc.
CUSIP
98937L105
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150 Q3 2024: 44Q3 2024Q4 2024: 65Q4 2024Q1 2025: 67Q1 2025Q2 2025: 73Q2 2025Q3 2025: 80Q3 2025Q4 2025: 119Q4 2025Q1 2026: 140Q1 2026Q2 2026: 144Q2 2026

Total Exit/New Position Q3 2024

InstitutionsTotal Value
New Positions44$418.5M
Exits0$0

Ownership 44 holders

SR One Capital Management, LP 16.66% New 4,911,539 $83.1M
NEA Management Company, LLC 2.41% New 2,613,948 $44.2M
FMR LLC 0.00% New 2,000,000 $33.8M
Fairmount Funds Management LLC 2.60% New 1,892,806 $32.0M
NVP Associates, LLC 17.66% New 1,838,482 $31.1M
Deerfield Management Company, L.P. 0.44% New 1,562,942 $26.4M
Wellington Management Group LLP 0.00% New 1,501,428 $24.8M
Vivo Capital, LLC 1.66% New 1,183,260 $20.0M
Federated Hermes, Inc. 0.04% New 1,158,000 $19.6M
Novo Holdings A/S 0.97% New 1,150,000 $19.5M
Perceptive Advisors LLC 0.42% New 1,144,035 $19.4M
Rock Springs Capital Management LP 0.48% New 878,667 $14.9M
Pivotal bioVenture Partners Investment Advisor LLC 6.54% New 650,695 $11.0M
T. Rowe Price Associates Inc. 0.00% New 486,854 $8.2M
ArrowMark Colorado Holdings LLC 0.07% New 300,000 $5.1M
Eversept Partners, LP 0.25% New 190,531 $3.2M
Monashee Investment Management LLC 0.28% New 150,000 $2.5M
Vanguard Group Inc. 0.00% New 150,000 $2.5M
Goldman Sachs Group Inc. 0.00% New 132,400 $2.2M
Millennium Management 0.00% New 117,381 $2.0M
Superstring Capital Management LP 1.69% New 111,605 $1.9M
Citadel Advisors 0.00% New 94,322 $1.6M
Aberdeen Group plc 0.00% New 75,100 $1.3M
Norges Bank 0.00% New 75,000 $1.3M
Point72 Asset Management 0.00% New 57,600 $975K
Morgan Stanley 0.00% New 51,050 $864K
Soros Fund Management 0.02% New 37,500 $635K
Squarepoint Ops LLC 0.00% New 32,299 $546K
Maven Securities LTD 0.06% New 31,054 $525K
Teachers Retirement System of the State of Kentucky 0.00% New 27,880 $472K
Point72 (DIFC) Ltd 0.03% New 26,129 $442K
M&T Bank Corp 0.00% New 24,884 $422K
Geode Capital Management, LLC 0.00% New 24,857 $421K
Barclays PLC 0.00% New 15,500 $262K
HRT Financial LP 0.00% New 15,463 $261K
Point72 Asia (Singapore) Pte. Ltd. 0.04% New 13,529 $229K
Two Sigma Investments, LP 0.00% New 13,000 $220K
Capula Management Ltd 0.00% New 10,615 $180K
Landscape Capital Management, L.L.C. 0.02% New 10,074 $170K
PNC Financial Services Group, Inc. 0.00% New 3,849 $65K
Cubist Systematic Strategies, LLC 0.00% New 3,762 $64K
Aster Capital Management (DIFC) Ltd 0.01% — 3,018 $51K
UBS Group AG 0.00% New 59 $998
MRP Capital Investments, LLC 0.00% New 35 $593

"% of holder's portfolio" is ZBIO's weight in each manager's 13F, not the share of Zenas Biopharma Inc. the manager owns.